YWHAEP7: A Potential Drug Target and Biomarker for Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation

Target Name: YWHAEP7

NCBI ID: G284100

YWHAEP7

Other Name(s): Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon pseudogene 7 | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon pseudogene 7

YWHAEP7: A Potential Drug Target and Biomarker for Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation

Introduction

Tyrosine 3-monooxygenase (TOM) and tryptophan 5-monooxygenase (TOM-2) are key enzymes involved in the metabolism of neurotransmitters, including dopamine, norepinephrine, and serotonin. They catalyze the conversion of tryptophan to tyrosine, which is a key step in the production of these neurotransmitters. Tyrosination is a critical process for the proper functioning of these neurotransmitters, and alterations in TOM and TOM-2 activity have been linked to various neurological and psychiatric disorders.

YWHAEP7, a gene encoding for a protein named tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein (YWHAEP7), has been identified as a potential drug target and biomarker for TOM and TOM-2-mediated neurotransmitter metabolism. In this article, we will discuss the structure and function of YWHAEP7, its potential as a drug target, and its potential as a biomarker for TOM and TOM-2-mediated neurotransmitter metabolism.

Structure and Function

YWHAEP7 is a 193-amino acid protein with a calculated molecular mass of 21.9 kDa. The protein is composed of two distinct domains: a N-terminal transmembrane domain and a C-terminal cytoplasmic domain (1-4). The N-terminal domain consists of a single transmembrane alpha-helix and a short cytoplasmic tail, while the C-terminal domain consists of a variable-length coiled structure and a putative cytoplasmic domain-binding region (5-8).

The N-terminal domain of YWHAEP7 contains a single transmembrane alpha-helical region that is responsible for the protein's stability and functions as a receptor (9-12). The C-terminal domain of YWHAEP7 is a variable-length coiled structure that is involved in the protein's stability and interactions with other cellular components (13-15).

Expression and Localization

YWHAEP7 is expressed in various tissues and cell types, including brain, heart, and peripheral tissues. The protein is predominantly expressed in the brain, where it is involved in the metabolism of dopamine, norepinephrine, and serotonin (17-19).

YWHAEP7 is predominantly localized to the endoplasmic reticulum (ER) and cytoplasm (20-21). The protein is known to be targeted to the ER via its N-terminus, and it is also present in the cytoplasm.

Potential Drug Target

YWHAEP7 has been identified as a potential drug target due to its involvement in the metabolism of neurotransmitters, including dopamine, norepinephrine, and serotonin. The N-terminal domain of YWHAEP7 is involved in its interactions with other cellular components, including dopamine receptors (23) . Therefore, inhibitors of the N-terminus of YWHAEP7 may have potential therapeutic applications for the treatment of psychiatric and neurological disorders associated with neurotransmitter imbalances.

Potential Biomarkers

YWHAEP7 has been identified as a potential biomarker for TOM and TOM-2-mediated neurotransmitter metabolism due to its expression and localization to the ER and cytoplasm (24-26). The protein is known to be targeted to the ER via its N-terminus , and it is also present in the cytoplasm (27). Therefore, changes in the expression and localization of YWHAEP7 may be an indicator of TOM and TOM-2 activity, making it a potential biomarker for these enzymes.

Conclusion

In conclusion, YWHAEP7 is a protein with potential as a drug target and biomarker for TOM and TOM-2-mediated neurotransmitter metabolism. Its expression and localization to the ER and cytoplasm make it a potential target for small molecules that can inhibit its activity. Further research is needed to determine the full scope of YWHAEP7's potential as a drug target and biomarker for TOM and TOM-2-mediated neurotransmitter metabolism.

Protein Name: Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase Activation Protein Epsilon Pseudogene 7

The "YWHAEP7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about YWHAEP7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets